Communications
2023 – 2021
2020 – 2017
2016 – 2014
2013 – 2010
before 2010
Economic burden of in-hospital AKI: a one-year analysis of the nationwide French hospital discharge database
Monard C, Rimmelé T, Blanc E, Goguillot M, Benard S, Textoris J
BMC Nephrol 24, 343 (2023). https://doi.org/10.1186/s12882-023-03396-8
Link to the articleIncidence of Nd:YAG laser capsulotomy following cataract surgery: a population-based nation-wide study – FreYAG1 study
Brezin A, Labbe A, Schweitzer C, Lignereux F, Rozot P, Goguillot M, Bugnard F, Dot C
BMC Ophthalmol 23, 417 (2023). https://doi.org/10.1186/s12886-023-03134-6
Link to the articleSuboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System
Gaujoux-Viala C, Bergmann JF, Goguillot M, Melaine A, Guerin M, Edouard A, Bénard S, Fautrel B
RMD Open 2023;9:e003075. doi: 10.1136/rmdopen-2023-003075
Link to the articlePrevalence and cost of sickle cell disease in France: real-world analysis using data from the Echantillon Généraliste des Bénéficiaires
Beillat M, Durand Zaleski I, Pirenne F, Chillotti L, Bénard S, Galacteros F
Front Public Health. 2023 Sep 21;11:1215605. doi: 10.3389/fpubh.2023.1215605.
Link to the articleHospital Costs in Resected Patients With Early-Stage Non-Small Cell Lung Cancer (NSCLC): A French Real-World Retrospective Study Based on the National Hospitalization Database (PMSI)
Renaud S., Brouquet A., Casabianca P., Diez-Andreu P., Chartier M., Reynaud D., Gaudin AF., Bugnard F., Bénard S., Cotte FE., Chouaid C.
Poster presented at the ISPOR congress, Copenhague, November 2023
Consideration of Competing Risks in Early Setting in Oncology and Impact on the Survival Estimates: To Explicitly Model Them? An Example of a French Real-World Cohort in Urothelial Carcinoma
Chillotti L., Colrat F., Diez-Andreu P., Brouquet A., Gaudin AF., Bugnard F., Bénard S., Branchoux S., Bellera C.
Poster presented at the ISPOR congress, Copenhague, November 2023
Cost-effectiveness of pembrolizumab plus chemotherapy, with or without bevacizumab for the first-line treatment of PD-L1-positive patients with persistent, recurrent, or metastatic cervical cancer in France
Ray-Coquard I., Pautier P., Muston D., Montberg M., Swami S., Chaker O., Bensimon L., Marié L, Lange S, Kulakova M, Durant-Zaleski I.
Poster presented at the ISPOR congress, Copenhague, November 2023
Cost-effectiveness of pembrolizumab as an adjuvant treatment for renal cell carcinoma post-nephrectomy in France
Gross-Goupil M, Apert M, Bensimon L, Marié L, Chau M, Baluni G, Chhabra N, Kundu A, Bhattacharya, Lai Y, Ouzaid I.
Poster presented at the ISPOR congress, Copenhague, November 2023
RSV Hospitalizations’ Burden in New-Born Patients and Potential Impact of Maternal Vaccination: A French Analysis
Fahfouhi Y, Fiévez S, Blanc E, Marié L, Densari Z, Chillotti L, Cancalon C, Kernaleguen C, Nuttens C
Poster presented at the ISPOR congress, Copenhague, November 2023
Eosinophilic Granulomatosis with Polyangiitis: Estimation of the Clinical and Economic Burden in France a Real-World Retrospective Study Based on the National Health Data System (SNDS)
Tauty S, Brouquet A, Bugnard F, Bénard S, Cottin V, Taillé C, Guillevin L, Puéchal X, Terrier B
Poster presented at the ISPOR congress, Copenhague, November 2023
Epidemiology and outcome of eosinophilic granulomatosis with polyangiitis in France
Terrier B, Taillé C, Brouquet A, Tauty S, Bugnard F, Guillevin L, Puéchal X, Cottin V
Abstract presented at the ACR Convergence 2023 meeting at San Diego ( November 10–15)
Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease – A population-based study
Sevin C, Hatteb S, Clement A, Bignami F, Chillotti L, Bugnard F, Bénard S, Boespflug-Tanguy O
Orphanet J Rare Dis 18, 238 (2023)
Link to the articlePrévalence et incidence de la granulomatose éosinophilique avec polyangéite et description des cas incidents en France
Terrier B, Brouquet A, Tauty S, Bugnard F, Guillevin L, Taillé C, Cottin V, Puéchal X
Abstract presented at the SNFMI congress, La Rochelle, July 2023
Traitements et complications observées au cours de la prise en charge de la granulomatose éosinophilique avec polyangéite : étude chez 1650 cas incidents issus du SNDS
Terrier B, Brouquet A, Tauty S, Bugnard F, Guillevin L, Cottin V, Puéchal X, Taillé C
Abstract presented at the SNFMI congress, La Rochelle, July 2023
Pronostic de la granulomatose éosinophilique avec polyangéite en France : données sur 1650 cas incidents issus du SNDS
Terrier B, Brouquet A, Tauty S, Bugnard F, Guillevin L, Puéchal X, Taillé C, Cottin V
Abstract presented at the SNFMI congress, La Rochelle, July 2023
Granulomatose éosinophilique avec polyangéite : estimation de l’épidémiologie et de son fardeau en France à partir des données du SNDS
Tauty S, Brouquet A, Bugnard F, Bénard S, Cottin V, Taillé C, Guillevin L, Puéchal X, Terrier B
Abstract presented at the DSVR congress, Paris, June 2023
Pratiques chirurgicales et impacts pronostiques dans le cancer bronchique non à petites cellules (CBNPC) traité par résection pulmonaire en France entre 2015 et 2020 – Étude BRONTES
Renaud S, Diez-Andreu P, Casabianca P, Chartier M, BrouquetA, Reynaud D, Gaudin AF, Bugnard F, Bénard S, Cotte FE, Chouaid C
Poster presented at the DSVR (Données de Santé en Vie Réelle) congress, Paris, June 2023
Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden – a real-world study using registry data linked to the French national claims database
Boespflug-Tanguy O, Chillotti L, Bugnard F, Dheyriat L, Bénard S, Sevin C
Poster presented at the ICPE (International Society for Pharmacoepidemiology) congress, Halifax, August 2023
Severity and burden of sickle cell disease (SCD) in France: a nationwide realworld study
Brousse V, Bernaudin F, Dheyriat L, Chillotti L, Goguillot M, Gallagher M, Bugnard F, Bénard S, Habibi A
Poster presented at the ICPE (International Society for Pharmacoepidemiology) congress, Halifax, August 2023
Identification des patients drépanocytaires nécessitant des transfusions régulières et description des consommations de soins et coûts associés avant et après l’initiation : analyse en population nationale française à partir du SNDS
Brousse V, Bernaudin F, Dheyriat L, Goguillot M, Gallagher M, Bugnard F, Bénard S, Habibi A
Poster presented at the DSVR (Données de Santé en Vie Réelle) congress, Paris, June 2023
Severity and burden of sickle cell disease in France: a nationwide realworld study
Brousse V, Bernaudin F, Melaine A, Goguillot M, Gallagher M, Benard S, Habibi A
Haematologica. 2023 Mar 16. doi: 10.3324/haematol.2022.282098.
Link to the articleReal-world evidence in transplanted patients with cytomegalovirus disease: Healthcare resource utilization and outcomes from a French national cohort study
Nucit A, Goguillot M, Maric M, Lefevre C, Bénard S, Cordonnier C, Kamar N, Saliba F
Poster presented at the JNI (Journées Nationales d’Infectiologie) congress, Grenoble, June 2023
Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study
Roupret M, Brouquet A, Colrat F, Diez-Andreu P, Prudent A, Chartier M, Gaudin AF, Bugnard F, Chillotti L, Bénard S, Branchoux S, Bellera C, Negrier S
World Journal of Urology 2023, s00345-023-04335-w
Link to the articleEpidémiologie, prise en charge et survie du cancer du poumon non à petites cellules de stade précoce traité par résection pulmonaire en France
Chouaid C, Diez-Andreu P, Casabianca P, Chartier M, BrouquetA, Reynaud D, Gaudin AF, BugnardF, Bénard S, Cotte FE, Renaud S
Poster présented at the CPLF (Congrès de Pneumologie en Langue Française), Marseille, January 2023
Incidence of retinal detachment, macular edema, and ocular hypertension after Nd:YAG capsulotomy: a population-based nationwide study – the FreYAG2 study
Dot C, Schweitzer C, Labbe A, Lignereux F, Rozot P, Goguillot M, Bugnard F, Brézin A
Ophthalmology. 2022 Dec 26:S0161-6420(22)01017-X. doi: 10.1016/j.ophtha.2022.12.023
Une faible utilisation du canakinumab dans la goutte en France : analyse du Système National des Données de Santé (SNDS) 2018-2020 (EPI-ILARIS)
Pascart T, Bardin T, Flipo RM, Saraux A, Schaeverbeke T, Tubach F, Jover M, Dheyriat L, Lioté F
Poster presented at the SFR (Société Française de Rhumatologie) congress, Paris, December 2022
“Actualisation des données épidémiologiques du diabète en France : l’étude APIDIA 2017 APIDIA 2017: an update of diabetes epidemiology in France”
Reznik Y, Naiditsch N, Thébault JF, Havet A, Bénard S, Riveline JP
Médecine des Maladies Métaboliques – Volume 16, Issue 7, November 2022, Pages 642-651
Link to the articleDevelopment of an algorithm to identify congenital Thrombotic Thrombocytopenic Purpura (cTTP) patients in the French National hospital database (PMSI)
Goguillot M, Lefèvre C, Favre-Besse FC, Pham A, Cancalon C, Bénard S, Coppo P
Poster présented at the SFVTT (Société Française de Vigilance et de Thérapeutique Transfusionnelle) conference, Montpellier, November 2022
Healthcare resource use and associated costs of dengue fever requiring hospitalization: a french national real-world study
Cancalon C, Lefèvre C, Pham A, Nucit A, Tabet Aoul W, Chassetuillier J, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Vienna, November 2022
Healthcare resource use and associated costs of congenital thrombotic thrombocytopenic purpura in France
Goguillot M, Lefevre C, Favre-Besse FC, Pham A, Cancalon C, Bénard S, Coppo P
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Vienna, November 2022
Epidemiology and Burden of Sickle Cell Disease in France: Real-Life Analysis using Data from the Echantillon Generaliste des Bénéficiaires (EGB)
Beillat M, Durand Zaleski I, Pirenne F, Chillotti L, Bénard S, Galacteros F
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Vienna, November 2022
Hospital Costs of Muscle-Invasive Urothelial Carcinoma (MIUC) Patients Undergoing Radical Surgery: A French Real-World Retrospective Study Based on the National Hospitalization Database (PMSI)
Negrier S, Brouquet A, Colrat F, Diez-Andreu P, Chartier M, Prudent A, Gaudin AF, Bénard S, Branchoux S, Roupret M, Bellera C
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Vienna, November 2022
Healthcare resource use (HCRU) and associated costs among patients with diffuse large B-cell lymphoma (DLBCL) treated with CAR-T cells in France – a real-world study using data from PMSI
Di Blasi R, Thieblemont C, Haioun C, Mayaud AC, Sackmann Sala L, Diez Andreu P, Bugnard F, Goguillot M, Chilotti L, Finzi J, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Vienna, November 2022
Treatment patterns among patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are ineligible for transplantation – a real-world study using French PMSI
Di Blasi R, Thieblemont C, Haioun C, Mayaud AC, Sackmann Sala L, Diez Andreu P, Bugnard F, Goguillot M, Chilotti L, Finzi J, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Vienna, November 2022
Epidémiologie et fardeau de la drépanocytose en France : analyse en vie réelle des données de l’échantillon généraliste des bénéficiares (EGB)
Alfa Cisse O, Durand-Zaleski I, Pirenne F, Chilotti L, Bénard S, Galacteros F
Poster presented at the CGRF (Club du Globule Rouge et du Fer) conference, Antibes, September 2022
Impact on health-economic evaluations of the extrapolation method regarding the efficacy of immunotherapies : case study in renal cell carcinoma
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Vienna, November 2022
Adrénoleukodystrophie cérébrale infantile en France : épidémiologie, histoire naturelle et fardeau – étude rétrospective sur une cohorte appariée aux données du SNDS
Chillotti L, Cancalon C, Goguillot M, Chassetuillier J, Bugnard F, Bénard S
Poster presented at DSVR (Données de Santé en Vie Réelle) conference, Paris, June 2022
Suboptimal management of rheumatoid arthritis in France: A real-life study based on data from the French national Health Insurance database
Gaujoux-Viala C, Bergmann JF, Goguillot M, Melaine A, Guerin M, Edouard A, Bénard S, Fautrel B
Poster presented at the European League Against Rheumatism (EULAR) congress, Copenhagen, June 2022
Optimisation d’un algorithme prédéfini en utilisant une analyse de clustering – Application à une cohorte de patients diabétiques issus de l’Échantillon Généraliste des Bénéficiaires (EGB)
Chassetuillier J, Cancalon C, Havet A, Bugnard F, Benard S
Oral presentation at the ADELF (Association des Epidémiologistes de Langue Française) conference, Dijon, March 2022
Real-life impact of uncontrolled severe asthma on mortality and healthcare use in adolescents and adults: findings from the retrospective, observational RESONANCE study in France
Roche N, Garcia G, de Larrard A, Cancalon C, Bénard S, Perez V, Mahieu A, Vieu L, Demoly P
BMJ Open 2022;12:e060160
Link to the articleA database study of clinical and economic burden of invasive meningococcal disease in France
Huang L, Fievez S, Goguillot M, Marie L, Bénard S, Elkaïm Anne, Htar MTT
PLoS ONE 17(4):e0267786
Updated evidence-based recommendations for cervical cancer screening in France
“Hamers F, Poullié AI, Arbyn M Stève Bénard a été membre du comité de travail”
Eur J Cancer Prev 2022,31(3):279-86
Prise en charge suboptimale de la polyarthrite rhumatoïde en France : Etude à partir des données de la base nationale de l’Assurance Maladie
Gaujoux-Viala C, Bergmann JF, Goguillot M, Melaine A, Guerin M, Edouard A, Bénard S, Fautrel B
Oral presentation of the SFR (Société Française de Rhumatologie) congress, Paris, December 2021
Cost-Utility of Acromegaly Pharmacological Treatments in a French Context
Brue T, Chanson P, Rodien P, Delemer B, Drui D, Marié L, Juban L, Salvi L, Henocque R, Raverot G
Front Endocrinol 2021,12:745843
Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data
Korobelnik JF, Delcourt C, Creuzot-Garcher C, Melaine A, Chassetuillier J, Lejeune A, Bénard S, Dupont-Benjamin L
J Med Econ 2021,24(1):1087-97
Link to the articleMapping health utilitiesfor patients with cerebral adrenoleucodystrophy using trial-based PedsQL™ scores
Paramore LC, Pan L, Autin E, Marie L, XU J
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) congress, Novembre 2021
Cost-effectiveness analysis of first-line systemic treatment in advanced renal cell carcinoma in France
Tempelaar S, Kroep S, Marie L, Juban L, Kurt M, Ejzykowicz F, May JR, Gaudin AF, Dhanji N, Branchoux S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), November 2021
Incidence of YAG laser capsulotomies and their complications in a large French population sample
Brezin A
Oral presentation at the European Society of Cataract and Refractive Surgeons (ERCRS) congress, Amsterdam, October 2021
Is the Health Data Hub a GOLD MINE for French health-economic evaluations?
Juban L, Chau M, Marie L, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, November 2020
Traitement de l’épilepsie par stimulation du nerf vague en France : Evolution et caractéristiques des patients à partir des données de la base PMSI
Cancalon C, Chassetuillier J, Bugnard F, Duvillard R, Bénard S
Poster presented at DSVR (Données de Santé en Vie Réelle) conference, Paris, September 2020
Prise en charge des patients victimes d’un AVC ischémique admis en UNV en France et impact d’une optimisation de la thrombolyse sur les parcours de soins et les coûts associés
Dreyfus L, Le Lay K, Caumette D, Bénard S, Marie L, Chassetuillier J, Héroum C
Poster presented at DSVR (Données de Santé en Vie Réelle) conference, Paris, September 2020
Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France
de Rycke Y, Tubach F, Lafourcade A, Guillo S, Dalichampt M, Dahlab A, Bresse X, Uhart M, Bergeron C, Borne H, Cancalon C, Lajoinie A, Benard S
Plos One 2020,15(2):e0228660
Link to the articleImpact en vie réelle de l’asthme sévère non contrôlé sur la morbi-mortalité des patients âgés de 12 ans et plus en France – Étude RESONANCE
Demoly P, Garcia G, Roche N
Oral presentation at CPLF (Congrès de Pneumologie de Langue Française), Paris, January 2020
Economic impact of sequelae related to invasive meningococcal disease in a French real-world setting
Fievez S, Htar MTT, Weller J, Goguillot M, Bénard S, Huang L
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Copenhague, November 2019
Cost-effectiveness analysis of nivolumab in combination with ipilimumab versus sunitinib for the first line treatment of intermediate to poor risk advanced renal cell carcinoma in France
Branchoux S, Négrier S, de Peretti C, Malcom B, May J, Marie L, Gaudin AF, Klijn S, Ignacio TJ
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Copenhague, November 2019
Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database
Cottin V, Avot D, Lévy-Bachelot L, Baxter C, Ramey DR, Catella L, Bénard S, Sitbon O, Teal S
Plos One 2019,14(4):e0214649
Link to the articleFrench efficiency opinions of the economic and public health committee (CEESP): Is there an impact on the market access for innovative drugs?
Schiele P, Porte F, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Barcelone, November 2018
Development and validation of an algorithm identifying chronic thrombopenic pulmonary hypertension (CTEPH) in hospital discharge databases
Cottin V, Teal S, Avot D, Lévy-Bachelot L, Baxter C, Ramey D, Palmaro A, Catella L, Bénard S, Sitbon O
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Barcelone, November 2018
Epidemiology, patient characteristics and in-hospital management of episodes of acquired thrombotic thrombopenic purpura (aTTP): a French real-life population based study
Goguillot M, Claverie-Chau I, Bénard S, Lajoinie A, De Naeyer L, Duvivier A, Coppo P
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Barcelone, November 2018
Clinical and Economic Burden of Invasive Meningococcal Disease in France
Fievez S, Htar MTT, Goguillot M, Bénard S, Huang L
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Barcelone, November 2018
Secondary use of existing personal health data for non-interventional studies in France (travail acollaboratif AFCRO)
Lajoinie A (AFCRO), Edel V, Serre JL
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Barcelone, November 2018
Epidemiological and economic burden of potentially HPV-related cancers in France
Abramowitz L, Lacau Saint Guily J, Moyal-Barracco M, Bergeron C, Borne H, Dahlab A, Bresse X, Uhart M, Cancalon C, Catella L, Bénard S
Plos One 2018,13(9):e0202564
Link to the articleIdentifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI)
Cottin V, Teal S, Avot D, Lévy-Bachelot L, Baxter C, Palmaro A, Catella L, Bénard S, Sitbon O
Poster présenté at the European Respiratory Society (ERS) congress, Paris, September 2018
Renal Replacement Therapy Modality in the ICU and Renal Recovery at Hospital Discharge
Bonnassieux M, Duclos A, Schneider AG, Schmidt A, Bénard S, Cancalon C, Joannes-Boyau O, Ichai C, Constantin JM, Lefrant JY, Kellum JA, Rimmelé T for the AzuRéa Group
Critical Care Medicine 2018,46(2):e102-10
Health economic evaluation in idiopathic pulmonary fibrosis in France
Porte F, Cottin V, Catella L, Luciani L, Le Lay K, Bénard S
Curr Med Res Opin. 2018,34(10):1731-40
Link to the articleBurden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study
Cottin V, Schmidt A, Catella L, Porte F, Fernandez-Montoya C, Le Lay K, Bénard S
PLOS One 2017,12(1):e0166462
Link to the articleOutcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures
Aubry P, Brillet G, Catella L, Schmidt A, Bénard S
BMC Neprhol 2016,17(1):176
Link to the articleNintedanib cost-utility in idiopathic pulmonary fibrosis in France
Bénard S, Schmidt A, Catella L, Porte F, Setton M, Fernandez-Montoya C, Le Lay K
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Vienne, November 2016
A cost-effectiveness analysis of secukinumab compared to current biologics sequences for the treatment of moderate to severe plaque psoriasis in France
Duteil E, Cariou C, Schmidt A, Benjamin K, Duco J-F
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Vienne, November 2016
New data on the burden of abnormal pap smears and hospitalised precancerous lesions in France (EGB and PMSI databases analysis)
Catella L, Cancalon C, Lafourcade A, de Rycke Y, Guillot S, Tubach F, Dalichampt M, Jacquard AC, Largeron N, Dahlab AF, Bresse X, Uhart M, Bergeron C, Borne H, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Vienne, November 2016
Epidemiology, treatment pathways and costs of cancers potentially related to HPV infection in France
Abramowitz L, Lacau Saint Guily J, Moyal-Barracco M, Jacquard AC, Largeron N, Dahlab AF, Bresse X, Uhart M, Bergeron C, Borne H, Cancalon C, Catella L, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Vienne, November 2016
Management of metastatic colorectal cancer patients: A methodological approach to identify treatment lines
Phelip JM, Porte F, Setton M, Le Lay K, Le Calvez K, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Vienne, November 2016
Idiopathic Pulmonary Fibrosis: Acute Events, Mortality and Associated Hospital Costs
Cottin V, Schmidt A, Catella L, Bénard S
Poster presented at the American Thoracic Society (ATS) congress, San Franciso, May 2016
Lifetime cost of meningococcal disease in France: Scenarios of severe meningitis and septicemia with purpura fulminans
Bénard S, Wright C, Voisine J, Olivier CW, Gaudelus J
J Infect Public Health 2016,9(3):339-47
Link to the articleStimulation électrique gastrique (SEG) pour vomissements réfractaires : résultats d’une étude contrôlée multicentrique en double aveugle
Ducrotté P, Coffin B, Matthieu N, Fontaine S, Bruley des varannes S, Zerbib F, Caiazzo R, Grimaud JC, Mion F, Hadjadj S, Petit C, Vuitton L, Ropert A, Altwegg R, Pouderoux P, Dorval E, Dapoigny M, Bonaz B, Sabate JM, Benhamou PY, Faucheron JL, Slim K, Schmidt A, Gourcerol G, Guerci B
Poster présented at JFHOD (Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive), Paris, March 2016
Link to the presentationParcours de soins des patients recevant un biomédicament
Faure P, LaharieP, Sibilia J, Sordet C, Ronfort A, Lamezec L, Dramard S, Schmidt A, Cordier S
Le Concours Médical 2016,3:187-89
Prise en charge de la fibrose pulmonaire idiopathique à l’hôpital : étude rétrospective longitudinale penant 5 ans
Cottin V, Schmidt A, Catella L, Bénard S
Poster presented at CPLF (Congrès de Pneumologie de Langue Française), Lille, January 2016
Hospital epidemiology and costs of pertussis in France: A retrospective database analysis
Gaillat J, Casez P, Pinquier D, Dommergue MA, Jacquard AC, Cancalon C, Bénard S
J Vaccines Immun 2015,3(3):13-8
Link to the articleHospital Cost of Staphylococcal Infection after Cardiothoracic or Orthopedic Operations in France: A Retrospective Database Analysis
Schmidt A, Bénard S, Cyr S
Surg Infect 2015,16(4):428-35
Link to the articleAcute Ischemic Stroke (AIS) Patient Management in French Stroke Units and Impact Estimation of Thrombolysis on Care Pathways and Associated Costs
Schmidt A, Heroumb C, Caumettec D, Le Lay K, Bénard S
Cerebrovascular Diseases 2015:39:94-101
Link to the articleNéphropathies induites par les produits de contraste iodés chez les patients hospitalisés pour un acte interventionnel en France : épidémiologie et analyse économique
Brillet G, Aubry P, Schmidt A, Catella L, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Milan, November 2015
Idiopathic pulmonary fibrosis: Hospital disease management and associated costs
Cottin V, Schmidt A, Catella L, Porte F, Fernandez-Montoya C, Le Lay K, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Milan, November 2015
Modalités continues ou intermittentes: évolution des pratiques en France et dans le monde
Rimmelé T
Oral presentation at SFAR (Société Francophone des Anésthésie et de Réanimation) congress, Paris, January 2015
Management of vitreomacular traction (VMT) by vitrectomy in France: a restrospective hospital database analysis (PMSI)
Bénard S, Schmidt A, Zech JC, Korobelnik JF, Guignard E, Moro L, Lescrauwaet B
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Montréal, June 2014
Current management of acute ischaemic stroke patients admitted in stroke units in France and the impact of optimising thrombolysis on care pathways and associated costs
Heroum C, Schmidt A, Bénard S
Poster presented at the European Stroke Conference, Nice, May 2014
Secure system for IV administrations: Health-economic impact of a “smart” infusion safety system
Schmidt A, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Prague, November 2014
Counting the cost of meningococcal disease in France
Faivre P, Bénard S, Wright C, Voisine J, Gaudelus J
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Dublin, November 2013
Parcours de soins des patients atteints de cancer bronchique traités chirurgicalementHospital undertaking of patients with a resection of lung cancer
Rivera C, Cancalon C, Schmidt A, Mazieres J, Falcozd PE, Dahan M, Benard S
Revue des Maladies Respiratoires 2013, 30(7):529-36
Link to the articleHospital costs of staphylococcal infection following cardiothoracic or orthopedic surgeries in France, 2009-2010
Schmidt A, Bénard S, Cyr S
Poster présented at the Intertanional on Staphylococci and Staphylococcal Infections (ISSSI) conference, Lyon, August 2012
Economic and organizational impact of the systematic use of single-hand secured Huber needle (positive pressure) in French hospitals
Levert H, Tournier C, Douard MC, Villiers S, Albert O and Bénard S
Poster presented at the World Congress of Vascular access (Wocova) congress, Amsterdam, June 2012
Health-economic analysis of the systematic use of single-hand secured Buber needles (positive pressure) in French hospitals
Levert H, Tournier C, Douard MC, Villiers S, Albert O and Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Berlin, November 2012
Fuites aériennes prolongées après résection pulmonaire : une étude descriptive nationale
Rivera C, Bernard A, Falcoz PE, Thomas P, Schmidt A, Bénard S, Vicaut E, Tiffet O, Filaire M, Dahan M
Chirurgie Thoracique Cardio-Vascualire 2011,15(3):161-69
Link to the articleFuite aérienne prolongée après résection pulmonaire en France : fréquence et construction d’un score prédictif
Schmidt A, Bénard S, Falcoz PE, Vicaut E, Rivera C, Dahan M
Poster presented at EPI-CLIN (Conférence Francophone d’Epidémiologie Clinique), Marseille, May 2011
See the reportCharacterization and prediction of prolonged air leak after pulmonary resection: a nationwide study setting up the index of prolonged air leak
Rivera C, Bernard A, Falcoz PE, Thomas P, Schmidt A, Bénard S, Vicaut E, Dahan M
Ann Thorac Surg 2011,92(3):1062-8
Link to the articleExelon dans la prise en charge du patient Alzheimer : aspects médico-économiques
Boussel J, Bénard S
Oral presentation at CNPG (Congrès Nationale des Professionnels de la Gériatrie), Paris, March 2011
Prolonged air leaks after pulmonary resection: a descriptive nation-wide study
Rivera C, Bernard A, Falcoz PE, Thomas P, Filaire M, Schmidt A, Bénard S, Vicaut E, Dahan M
Poster presented at the Society of Thoracic Surgeons (STS) congress, Fort Laudardale, January 2010
Cost-minimization analysis of XELOX vs. FOLFOX-6 as first-line treatment of metastatic colorectal cancer in France
Perrocheau G, Bennouna J, Ducreux M, Hebbar M, Ychou M, Lledo G, Conroy T, Dominguez S, Florentin V, Douillard JY
Oncology 2010,79(3-4):174-80
Link to the articleHospital undertaking of patients with a resection of lung tumor in France
Cancalon C, Schmidt A, Bénard S
Poster présented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Prague, November 2010
Evaluation of a Hospital-Home Medical Program (HHMP) for the management of chemotherapy-related toxicities in the outpatient setting
Coriat R, Martin I, Forgeot d’Arc P, Mir O, Ropert S, Durand JP, Alexandre J, Koba S, Goldwasser F
Poster presented at the European Society of Medical Oncology (ESMO) congress, Milan, October 2010
See the reportHealthcare utilisation and costs of resected squamous cell carcinoma of head and neck (SCCHN) in France
Kim K, Faivre P, Cancalon C, Schmidt A, Amonkar M, Lykopoulos K, Bénard S, Högberg D, Kasteng F
Poster présented at the European Society for Therapeutic Radiology and Oncology (ESTRO) congress, Barcelone, September 2010
La base PMSI : outil épidémiologique et économique au niveau régional – Exemples des cancers de la tête et du cou
Cancalon C, Schmidt A, Bénard S
Poster presented at ADELF (Association des Epidémiologistes de Langue Française) conference, Bordeaux, April 2010
Evaluation de l’impact d’un suivi téléphonique systématique des patients traités par chimio-antitumorale pour tumeurs solides
Coriat R, Martin I, Forgeot d’Arc P, Ropert S, Durand JP, Brédart A, Levrat F, Schmidt A, Goldwasser F
Poster presented at JFHOD (Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive), Paris, March 2010
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer
Conroy T, Hebbar M, Bennouna J, Ducreux M, Ychou M, Llédo G, Adenis A, Faroux R, Rebischung C, Kockler L, Douillard JY
Br J Cancer 2010,102:59–67
Link to the articleQuality of life of patients with metastatic colorectal cancer receiving either XELOX or FOLFOX-6 regimen: a randomized phase III study
Conroy T, Hebbar M, Bennouna J, Ducreux M, Ychou M, Llédo G, Adenis A, Faroux R, Rebischung C, Kockler L, Douillard JY
Poster presented at the European Society of Medical Oncology – Gastro-Enterology (ESMO GI), Zurich, March 2009
Hospital burden related to upper aerodigestive tract cancers in France
Cancalon C, Schmidt A, Bénard S
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR), Paris, November 2009
Bénéfices de la vaccination contre le rotavirus avec le vaccin pentavalent, en France
Huet F, Bénard S, Quilici S, Trichard M
Oral presentation at the French Society of Paediatrics (SFP), Toulouse, June 2009
Economic evaluation of a pentavalent universal rotavirus vaccination programme in France
Bénard S, Quilici S
Poster presented at the European Society for Paediatric Infectious Diseases (ESPID), Bruxelles, June 2009
Cost-minimization analysis of XELOX vs. FOLFOX-6 as first-line treatment of metastatic colorectal cancer in France
Perrocheau G, Bennouna J, Ducreux M, Hebbar M, Ychou M, Lledo G, Conroy T, Dominguez S, Florentin V, Douillard JY
Poster presented at the American Society of Clinical Oncology (ASCO) congress, Orlando, June 2009
Comment analyser l’impact médico-économique d’un nouveau programme de vaccination ? Exemple du vaccin pentavalent contre le rotavirus en France
Quilici S, Bénard S, Trichard M, Huet F
Oral presentation at the 4th pharmaco-épidémiology conference, Paris, May 2009
Health and economic impact associated with a quadrivalent HPV vaccine in Italy
Mennini FS, Giorgi Rossi P, Palazzo F, Largeron N
Gynecol Oncol 2009,112(2):370-6
Link to the articleBurden of rotavirus gastroenteritis and potential benefits of a pentavalent rotavirus vaccination in Belgium
Dhont P, Trichard M, Largeron N, Rafia R, Bénard S
J Med Econ 2008,11(3):431-48
Link to the articleCosts of herpes zosterand post-hepertic neuralgia in France
Bénard S, Pinchinat S, Gallais JL, Mick G, Simon F, Beillat M
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Athens, November 2008
Cost of screening and treatment of cervical dyskaryosis in Germany
Petry KU, Breugelmans JG, Bénard S, Lamure E, Littlewood KJ, Hillemanns P
Eur J Gynaecol Oncol 2008,29(4):345-9
Link to the articleEstimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study
Hillemans P, Breugelmans JG, Gieseking F, Benard S, Lamure E, Littlewood KJ, Perty KU
BMC Infectious Disease 2008,8(76)
Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
Szucs T, Largeron N, Dedes KJ, Rafia R, Bénard S
Curr Med Res Opin 2008,24(5):1473-83
Link to the articleAdding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
Kulasingam, S, Bénard S, Barnabas RV, Largeron N, Myers E
Cost Eff Resour Alloc 2008,6(4)
Link to the articleBurden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq® in France
Huet F, Largeron N, Trichard M, Miadi-Fargier H, Jasso-Mosquedac G
Vaccine 2007,25(34)6348-58
Link to the articleCoût de la prise en charge du cancer invasif du col de l’utérus en France
Arveux P, Bénard S ,Bouée S, Lafuma A, Martin L, Cravello L, Remy V, Breugelmans JG
Bull Cancer 2007,94(2):219-24
Link to the articleIncidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France
Monsonego J, Breugelmans JG, Bouée S, Lafuma A, Bénard S, Remy V
Gynecol Obstet Fertil 2007,35:107-13
Link to the articleCoût du dépistage et de la prise en charge des lésions précancéreuses du col utérin en France
Bergeron C, Breugelmans JG, Bouée S, Lorans C, Bénard S, Remy V
Gynecol Obstet Fertil 2006,34:1036-42
Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK
Brown RE, Breugelmans JG, Theodoratou D, Bénard S
Curr Med Res Opin 2006,22(4):663-70
Link to the articleGenital warts incidence, medical management and costs in France
Monsonego J, Breugelmans JG, Bouée S, Bénard S
Poster presented at EUROGIN, Nice, November 2006
Invasive cervical cancer treatment costs in France
Arveux P, Breugelmans JG, Cravello L, Martin L, Bouée S, Bénard S
Poster presented at EUROGIN, Nice, November 2006
Cervical cancer screening and treatment costs in France
Bergeron C, Bénard S, Bouée S, Breugelmans JG
Poster presented at EUROGIN, Nice, November 2006
The developpement of a dynamique transmission model to assess the potential impact of a prophylactic quadrivalent HPV vaccine
Breugelmans JG, Garnett GF, Barnabas R, Bénard S
Poster presented at the European Programme for Intervention Epidemiology Training (EPIET), Menorca, October 2005
Adding a quadrivalent (6, 11, 16 & 18 types) human papillomavirus vaccine to the existing UK cervical sceening programme is potentially cost-effective
Kulasingam S, Bénard S, Barnabas R, Myers E
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Florence, November 2005
Incidence , prevalence and costs of treating genital warts in the pre-HPV vaccine era in Germany, 2005
Gieseking F, Petry KU, Hillemanns P, Germé M, Littlewood KJ, Bénard S, Breugelmans JG
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Florence, November 2005
Resource use and costs associated with the management of Pap III, Pap IIId and Pap IV in the pre-HPV vaccine era in Germany
Petry KU, Hillemanns P, Germé M, Littlewood KJ, Bénard S, Breugelmans JG
Poster presented at the International Society of Pharmacoeconomics and Outcomes Researche (ISPOR) congress, Florence, November 2005
Cost-Effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis with multiple organ failure in France
Riou-França L, Launois R, Guidet B, Aegerter P, Bénard S, Pinton P, Meshaka P
Poster presented at the International Health-Economic Association (iHEA) Conference, San Francisco, July 2003
